Zhang Y, et al. Global Patterns and Trends in Lung Cancer Incidence: A Population-Based Study. J Thorac Oncol. 2021;16(6):933–44.

Article  PubMed  Google Scholar 

Siegel RL, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

Article  PubMed  Google Scholar 

Oser MG, et al. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015;16(4):e165–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zheng M. Classification and Pathology of Lung Cancer. Surg Oncol Clin N Am. 2016;25(3):447–68.

Article  PubMed  Google Scholar 

Huang CY, et al. A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei). 2017;7(4):23.

Article  PubMed  Google Scholar 

Shafiei G et al. Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment of colon cancer cells. Front Pharmacol. 2023;14:1174120

Davoudi Z, et al. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells. Asian Pac J Cancer Prev. 2014;15(10):4353–8.

Article  PubMed  Google Scholar 

Abdulzehra S, Jafari-Gharabaghlou D, Zarghami N. Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells. Heliyon, 2023;9(11):e21400

Olaku O, White JD. Herbal therapy use by cancer patients: a literature review on case reports. Eur J Cancer. 2011;47(4):508–14.

Article  PubMed  Google Scholar 

Luo H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14(1):48.

Article  PubMed  PubMed Central  Google Scholar 

Kamarudin MNA, et al. Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. J Exp Clin Cancer Res. 2019;38(1):1–23.

Article  Google Scholar 

Yang B, Shi J. Developing new cancer nanomedicines by repurposing old drugs. Angew Chem Int Ed. 2020;59(49):21829–38.

Article  CAS  Google Scholar 

Yu H, et al. The Potential Effect of Metformin on Cancer: An Umbrella Review. Front Endocrinol (Lausanne). 2019;10:617.

Article  PubMed  CAS  Google Scholar 

Saraei P, et al. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019;11:3295–313.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gupta G, et al. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med. 2018;60(2):70–5.

Article  PubMed  Google Scholar 

Ghorbanzadeh F, et al. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression. Med Oncol. 2023;40(9):255.

Article  PubMed  CAS  Google Scholar 

Jafari-Gharabaghlou D, et al. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application. Mol Biol Rep. 2023;50(4):3023–33.

Article  PubMed  CAS  Google Scholar 

Jafari-Gharabaghlou D, Jabbari A, Soltani A. 187P Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: possible action through leptin gene and its receptor regulation. Ann Oncol. 2022;33:S116.

Article  Google Scholar 

Xiao K, et al. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. J Clin Pharm Ther. 2020;45(4):783–92.

Article  PubMed  CAS  Google Scholar 

Mohammadinejad S, Jafari-Gharabaghlou D, Zarghami N. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines. Asian Pac J Cancer Prev: APJCP. 2022;23(12):4063.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zi F, et al. Metformin and cancer: An existing drug for cancer prevention and therapy. Oncol Lett. 2018;15(1):683–90.

PubMed  Google Scholar 

Hassani N, et al. The effect of dual bioactive compounds artemisinin and metformin co-loaded in PLGA-PEG nano-particles on breast cancer cell lines: potential apoptotic and anti-proliferative action. Appl Biochem Biotechnol. 2022;194(10):4930–45.

Article  PubMed  CAS  Google Scholar 

Konstat-Korzenny E et al. Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer. Med Sci (Basel). 2018;6(1):19

Li D, Zhang J, Zhao X. Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment. Cancer Invest. 2021;39(8):675–84.

Article  PubMed  Google Scholar 

Kiani BH, et al. Artemisinin and its derivatives: a promising cancer therapy. Mol Biol Rep. 2020;47(8):6321–36.

Article  PubMed  CAS  Google Scholar 

Alibakhshi A, et al. An update on phytochemicals in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem. 2016;23(22):2380–93.

Article  PubMed  CAS  Google Scholar 

Zhang Q, et al. Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis. J Cancer. 2021;12(13):4075–85.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mokhtari RB, et al. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022.

Article  PubMed Central  Google Scholar 

Dashti MR, et al. G Protein-Coupled Receptor 75 (GPR75) As a Novel Molecule for Targeted Therapy of Cancer and Metabolic Syndrome. Asian Pac J Cancer Prev. 2023;24(5):1817–25.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Firouzi-Amandi A, et al. Development, characterization, and in vitro evaluation of cytotoxic activity of Rutin loaded PCL-PEG nanoparticles against Skov3 ovarian cancer cell. Asian Pac J Cancer Prev: APJCP. 2022;23(6):1951.

Article  PubMed Central  CAS  Google Scholar 

Alagheband Y, et al. Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment. J Drug Deliv Sci Technol. 2022;73:103389.

Article  CAS  Google Scholar 

Monsen RC, et al. The hTERT core promoter forms three parallel G-quadruplexes. Nucleic Acids Res. 2020;48(10):5720–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hannen R, Bartsch JW. Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett. 2018;592(12):2023–31.

Article  PubMed  CAS  Google Scholar 

Khosravi-Maharlooei M, et al. Expression pattern of alternative splicing variants of human telomerase reverse transcriptase (hTERT) in cancer cell lines was not associated with the origin of the cells. Int J Mol Cell Med. 2015;4(2):109.

PubMed  PubMed Central  Google Scholar 

Chen RJ, et al. P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment. Cell Death Dis. 2017;8(8):e2985.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barkhordari A, et al. Potential Anti-Cancer Effect of Helenalin as a Natural Bioactive Compound on the Growth and Telomerase Gene Expression in Breast Cancer Cell Line. Asian Pac J Cancer Prev: APJCP. 2023;24(1):133.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Suvarna V, Singh V, Murahari M. Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy. Eur J Pharmacol. 2019;862:172655.

Article  PubMed  CAS  Google Scholar 

Carrington EM, et al. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ. 2017;24(5):878–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou M, et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer. 2018;143(4):921–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Walsh JG, et al. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci. 2008;105(35):12815–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lamkanfi M, Kanneganti T-D. Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol. 2010;42(1):21–4.

Article  PubMed  CAS